Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT02128932

Public ClinicalTrials.gov record NCT02128932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 27, 2026, 11:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as Add on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Africa, North and South America, Asia and Europe. The purpose of the trial is to compare the effect of once-weekly dosing of two dose levels of semaglutide versus insulin glargine once-daily on glycaemic control after 30 weeks of treatment in insulin-naïve subjects with type 2 diabetes.

Study identification

NCT ID
NCT02128932
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,089 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 3, 2014
Primary completion
Sep 2, 2015
Completion
Sep 2, 2015
Last update posted
Jun 12, 2019

2014 – 2015

United States locations

U.S. sites
136
U.S. states
34
U.S. cities
120
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35216 —
Novo Nordisk Investigational Site Ozark Alabama 36360 —
Novo Nordisk Investigational Site Tuscumbia Alabama 35674 —
Novo Nordisk Investigational Site Gilbert Arizona 85295 —
Novo Nordisk Investigational Site Phoenix Arizona 85018 —
Novo Nordisk Investigational Site Phoenix Arizona 85032 —
Novo Nordisk Investigational Site Anaheim California 92801 —
Novo Nordisk Investigational Site Carmichael California 95608 —
Novo Nordisk Investigational Site Chula Vista California 91911 —
Novo Nordisk Investigational Site Elk Grove California 95758 —
Novo Nordisk Investigational Site Inglewood California 90301 —
Novo Nordisk Investigational Site La Mesa California 91942 —
Novo Nordisk Investigational Site Long Beach California 90807 —
Novo Nordisk Investigational Site Los Angeles California 90057 —
Novo Nordisk Investigational Site Oceanside California 92056 —
Novo Nordisk Investigational Site Orange California 92868-2863 —
Novo Nordisk Investigational Site Pomona California 91767-3008 —
Novo Nordisk Investigational Site Rialto California 92376 —
Novo Nordisk Investigational Site Rolling Hills Estates California 90274 —
Novo Nordisk Investigational Site Roseville California 95661 —
Novo Nordisk Investigational Site San Diego California 92111 —
Novo Nordisk Investigational Site San Mateo California 94401 —
Novo Nordisk Investigational Site Sherman Oaks California 91403 —
Novo Nordisk Investigational Site Spring Valley California 91978 —
Novo Nordisk Investigational Site Tustin California 92780 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Colorado Springs Colorado 80909 —
Novo Nordisk Investigational Site Denver Colorado 80220 —
Novo Nordisk Investigational Site Denver Colorado 80239-3133 —
Novo Nordisk Investigational Site Clearwater Florida 33761 —
Novo Nordisk Investigational Site Cooper City Florida 33024 —
Novo Nordisk Investigational Site Hialeah Florida 33012 —
Novo Nordisk Investigational Site Jacksonville Florida 32205 —
Novo Nordisk Investigational Site Jacksonville Florida 32216 —
Novo Nordisk Investigational Site Jacksonville Florida 32256 —
Novo Nordisk Investigational Site Kissimmee Florida 34741 —
Novo Nordisk Investigational Site Lakeland Florida 33805 —
Novo Nordisk Investigational Site Miami Florida 33135 —
Novo Nordisk Investigational Site Miami Florida 33156 —
Novo Nordisk Investigational Site Miami Lakes Florida 33016 —
Novo Nordisk Investigational Site Spring Hill Florida 34609 —
Novo Nordisk Investigational Site Winter Haven Florida 33880 —
Novo Nordisk Investigational Site Winter Park Florida 32789 —
Novo Nordisk Investigational Site Conyers Georgia 30013 —
Novo Nordisk Investigational Site Johns Creek Georgia 30097 —
Novo Nordisk Investigational Site Marietta Georgia 30060 —
Novo Nordisk Investigational Site Norcross Georgia 30092 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Meridian Idaho 83646 —
Novo Nordisk Investigational Site Chicago Illinois 60611 —
Novo Nordisk Investigational Site Gurnee Illinois 60031 —
Novo Nordisk Investigational Site Peoria Illinois 61602 —
Novo Nordisk Investigational Site Avon Indiana 46123 —
Novo Nordisk Investigational Site Indianapolis Indiana 46254 —
Novo Nordisk Investigational Site Council Bluffs Iowa 51501 —
Novo Nordisk Investigational Site Park City Kansas 67219 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Madisonville Kentucky 42431 —
Novo Nordisk Investigational Site Paducah Kentucky 42003 —
Novo Nordisk Investigational Site Lake Charles Louisiana 70601 —
Novo Nordisk Investigational Site Metairie Louisiana 70002 —
Novo Nordisk Investigational Site Natchitoches Louisiana 71457-5881 —
Novo Nordisk Investigational Site Shreveport Louisiana 71107 —
Novo Nordisk Investigational Site Hyattsville Maryland 20782 —
Novo Nordisk Investigational Site Buckley Michigan 49620 —
Novo Nordisk Investigational Site Flint Michigan 48504 —
Novo Nordisk Investigational Site Sterling Heights Michigan 48310-3503 —
Novo Nordisk Investigational Site Troy Michigan 48098 —
Novo Nordisk Investigational Site St Louis Missouri 63128 —
Novo Nordisk Investigational Site St Louis Missouri 63141 —
Novo Nordisk Investigational Site Butte Montana 59701 —
Novo Nordisk Investigational Site Las Vegas Nevada 89109 —
Novo Nordisk Investigational Site Las Vegas Nevada 89119 —
Novo Nordisk Investigational Site Las Vegas Nevada 89120 —
Novo Nordisk Investigational Site Berlin New Jersey 08009 —
Novo Nordisk Investigational Site Toms River New Jersey 08755-8050 —
Novo Nordisk Investigational Site Trenton New Jersey 08611 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87108 —
Novo Nordisk Investigational Site Brooklyn New York 11229 —
Novo Nordisk Investigational Site New Windsor New York 12553 —
Novo Nordisk Investigational Site West Seneca New York 14224 —
Novo Nordisk Investigational Site Greensboro North Carolina 27408 —
Novo Nordisk Investigational Site Morehead City North Carolina 28557 —
Novo Nordisk Investigational Site Morganton North Carolina 28655 —
Novo Nordisk Investigational Site Shelby North Carolina 28150 —
Novo Nordisk Investigational Site Statesville North Carolina 28625 —
Novo Nordisk Investigational Site Wilmington North Carolina 28401 —
Novo Nordisk Investigational Site Fargo North Dakota 58104 —
Novo Nordisk Investigational Site Canal Fulton Ohio 44614 —
Novo Nordisk Investigational Site Carlisle Ohio 45005 —
Novo Nordisk Investigational Site Cincinnati Ohio 45219 —
Novo Nordisk Investigational Site Cincinnati Ohio 45227 —
Novo Nordisk Investigational Site Cincinnati Ohio 45242 —
Novo Nordisk Investigational Site Cincinnati Ohio 45255 —
Novo Nordisk Investigational Site Cleveland Ohio 44122 —
Novo Nordisk Investigational Site Kettering Ohio 45429 —
Novo Nordisk Investigational Site Mason Ohio 45040-6815 —
Novo Nordisk Investigational Site Maumee Ohio 43537 —
Novo Nordisk Investigational Site Toledo Ohio 43623 —
Novo Nordisk Investigational Site Corvallis Oregon 97330-3737 —
Novo Nordisk Investigational Site Altoona Pennsylvania 16602 —
Novo Nordisk Investigational Site Beaver Pennsylvania 15009 —
Novo Nordisk Investigational Site Clairton Pennsylvania 15025-3730 —
Novo Nordisk Investigational Site Jersey Shore Pennsylvania 17740 —
Novo Nordisk Investigational Site Lansdale Pennsylvania 19446-1002 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19114 —
Novo Nordisk Investigational Site Gaffney South Carolina 29341 —
Novo Nordisk Investigational Site Murrells Inlet South Carolina 29576 —
Novo Nordisk Investigational Site Rapid City South Dakota 57701 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404 —
Novo Nordisk Investigational Site Knoxville Tennessee 37912 —
Novo Nordisk Investigational Site Amarillo Texas 79106 —
Novo Nordisk Investigational Site Austin Texas 78756 —
Novo Nordisk Investigational Site Dallas Texas 75251 —
Novo Nordisk Investigational Site Fort Worth Texas 76117 —
Novo Nordisk Investigational Site Houston Texas 77040 —
Novo Nordisk Investigational Site Houston Texas 77055 —
Novo Nordisk Investigational Site Houston Texas 77058 —
Novo Nordisk Investigational Site Houston Texas 77070 —
Novo Nordisk Investigational Site Houston Texas 77074 —
Novo Nordisk Investigational Site Humble Texas 77338 —
Novo Nordisk Investigational Site Hurst Texas 76054 —
Novo Nordisk Investigational Site Irving Texas 75061-2210 —
Novo Nordisk Investigational Site Longview Texas 75605 —
Novo Nordisk Investigational Site Marshall Texas 75670 —
Novo Nordisk Investigational Site Plano Texas 75075 —
Novo Nordisk Investigational Site San Antonio Texas 78209 —
Novo Nordisk Investigational Site San Antonio Texas 78229 —
Novo Nordisk Investigational Site Salt Lake City Utah 84107 —
Novo Nordisk Investigational Site St. George Utah 84790 —
Novo Nordisk Investigational Site Arlington Virginia 22206 —
Novo Nordisk Investigational Site Winchester Virginia 22601 —
Novo Nordisk Investigational Site Olympia Washington 98502 —
Novo Nordisk Investigational Site Renton Washington 98057 —
Novo Nordisk Investigational Site Wenatchee Washington 98801-2028 —
Novo Nordisk Investigational Site Kenosha Wisconsin 53144 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02128932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2019 · Synced Sep 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02128932 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →